On May 21, MicroPort Robot-B rose 5.32% in regular trading, trading at 26.84 HKD/share, with trading volume of approximately 49.46 million HKD.

On the news front, multiple positive catalysts have converged in recent days. On May 14, the company announced a proposed share buyback of up to 10% of total issued shares (1,031,330,331 shares comprising 609,745 domestic shares and 1,030,720,586 H-shares), subject to shareholder approval at the annual general meeting. On the same date, the board resolved to adopt a share incentive plan to reward qualified participants for their contributions to the group. Additionally, Citibank added the company to its preferred buy list for Hong Kong healthcare stocks, noting the medtech industry has entered a valuation reassessment phase. The company also recently completed the world's first large-model-based autonomous surgery animal experiment, reinforcing market expectations for its long-term technological competitiveness.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)